Skip to content
OpenCapital
Get started

MiMedx Group MDXG Q1 2025 earnings

Reported April 30, 2025 · After market close

Revenue$88.2MBeat by $1.9M
EPS$0.06In line
Revenue estimate$86.3M
EPS estimate$0.06

Next report

Date not yet announced

Financials

Q1 2025

Income statement

See full
Revenue$88.2M+4.1%
Gross profit$71.6M-0.1%
Operating income$8.3M-37.5%
Net income$7.0M-24.2%
EPS (diluted)$0.05-16.7%

Balance sheet

See full
Cash & equivalents$106.4M+120%
Total debt$18.7M-4.1%
Total equity$202.8M+30.2%
Total assets$270.4M+22.0%

Cash flow

See full
Operating cash flow$5.3M-11.4%
CapEx$377.0K-67.0%
Free cash flow$4.9M+1.8%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.12B-1.0%
Enterprise value$1.03B-6.4%
P/E27.9×+12.3×
P/S3.2×-0.2×

Profitability

See full
Gross margin81.9%-1.6pp
Operating margin15.3%-0.7pp
Net margin11.4%-10.3pp
FCF margin18.3%+8.1pp

Returns & leverage

See full
Return on equity22.4%—
Debt / equity0.1×0.0×
Current ratio4.7×+1.4×

Segments

By product

See full
Wound$56.1M-1.7%
Surgical$32.1M+16.2%

Versus estimates

Revenue

Q2 2026$64.4MBeat by $901.6KQ1 2026$59.0MMiss by $6.8MQ4 2025$118.1MBeat by $11.3MQ3 2025$113.7MBeat by $6.8MQ2 2025$98.6MBeat by $5.3M
Q1 2025$88.2MBeat by $1.9M

Diluted EPS

Q2 2026-$0.05Miss by $0.02Q1 2026-$0.05Beat by $0.02Q4 2025$0.14Beat by $0.05Q3 2025$0.15Beat by $0.08Q2 2025$0.10Beat by $0.04
Q1 2025$0.06In line

Ask the moment MiMedx Group reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MiMedx Group report Q1 2025 earnings?
MiMedx Group (MDXG) reported Q1 2025 earnings on April 30, 2025 after market close.
What were MiMedx Group's Q1 2025 revenue and EPS?
MiMedx Group reported revenue of $88.2M and eps of $0.06 for Q1 2025.
Did MiMedx Group beat estimates in Q1 2025?
Revenue beat the consensus estimate of $86.3M by $1.9M. EPS beat the consensus estimate of $0.06 by $0.00.
How did MiMedx Group's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.1% from $84.7M a year earlier and eps declined 14.3% from $0.07.
Where can I find MiMedx Group's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001376339-25-000045) directly on SEC EDGAR. The filing index links above go to sec.gov.